Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers – a potential link to low-melatonin syndrome in depression?

Neuroendocrinology

Volumn 65, Issue 4, 1997, Pages 284-290

  Kellner, Michael ^a   Yassouridis, Alexander ^a   Manz, Bernhard ^a   Steiger, Axel ^a   Holsboer, Florian ^a   Wiedemann, Klaus ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Adrenal steroids; Clinical neuroendocrinology; Corticotropin; Corticotropin releasing hormone; Depression; Melatonin; Sleep

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; MELATONIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NIGHT SLEEP; PINEAL BODY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; MALE; MELATONIN; SLEEP;

EID: 0030893616     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127186     Document Type: Article

References (45)

1. Miles A, Philbrick DRS: Melatonin and psychiatry. Biol Psychiatry 1988:23:405-425.
2. Wetterberg L, Aperia B: The relationship between the pineal gland and the pituitary-adrenal axis in health, endocrine and psychiatric conditions. Psychoncuroendocrinology 1983:8: 75-80.
3. Beck-Friis J, Ljundgren JG, Thoren M, von Rosen D. Kjellman BF. Wetterberg L: Melatonin. cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamcthasone suppression test. Psychoneu-roendocrinologv 1985:10:173-186.
4. Wurtman R. Altshule M. Holmgren U: Effect of pinealectomy and a bovine pineal extract in rats. Am J Physiol 1959;197:108-110.
5. Burden J, Hillhouse EW, Jones MT: The inhibitory action of GABA and melatonin on the release of corticotropin-releasing hormone from the rat hypophysiotrophic area in vitro. J Physiol (Lond) 1974:239:116P-117P.
6. Jones MT, Hillhouse EW, Burden J: Effect on various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro -A model of the neurotransmitters involved. J Endocrinol 1976;69:1-10.
7. Yasin SA, Costa A. Besser GM, Hucks D, Grossman A, Forsling ML: Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 1993:132:1329-1336.
8. Weidenfeld Y, Schmidt U, Nir I: The effect of exogenous melatonin on the hypothalamic-pituitary-adrenal axis in intact and pinealecto-mized rats under basal and stressed conditions. J Pineal Res 1993;14:60-66.
9. Vacas MI, Keller Sarmiento MI, Pcreyra EN, Etchegoyen GS, Carinali DP: In vitro effects of adrenohypophyseal hormones on rat pineal gland melatonin content and release. Mol Cell Endocrinol 1987.50:23-27.
10. Bauer MS, Poland RE, Whybrow PC, Frazer A: Pituitary-adrenal and thyroid effects on melatonin content of the rat pineal gland. Psychoneuroendocrinology 1989; 14:165-175.
11. Deacon S, Arendt J: Posture influences melatonin concentrations in plasma and saliva in humans. Ncurosci Lett 1994; 167:191-194.
12. Manz B, Seidel A, Alexander H, Vollrath L, Wagner B. Zimmcrmann G. Wiedemann K. Pollow K: Development and validation of a radioimmunoassay for serum melatonin. J Clin Client Clin Biochcm 1989;27:797-802.
13. Rechtschaffen A, Kales A: A Manual of Standardized Terminology. Techniques, and Scoring System for Sleep Stages of Human Subjects. Washington. Department of Health. Education, and Welfare. 1968.
14. Lauer CJ, Schreiber W, Holsboer F, Krieg JC: In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 1995:52:145-153.
15. Holsboer F, Spengler D, Heuser I: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia; in Swaab DF. Hofmann MA. Mirmiran M, Ravid R, van Lceuwen FW (eds): Progress in Brain Research. Amsterdam. Elsevier. 1992, pp 385-417.
16. Gold PW, Chrousos G, Kellner D, Post R, Roy A, Augcrinos P, Schulte H, Oldfield E. Loriaux DL: Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 1984:141:619-627.
17. Ncmeroff CB: The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 1988:21:76-82.
18. McIntyre IM, Judd FK, Marriott PM, Burrows GD, Norman TR: Plasma melatonin levels in affective states. Int J Clin Pharmacol Res 1989; 9:159-164.
19. Chccklcy SA, Park SBG: The psychopharmacology of the human pineal. J Psychopharma-col 1987;2:109-125.
20. Zetin M. Polkin S. Urbanchck M: Melatonin in depression. Psychiatr Ann 1987;17:676-681.
21. Sack RL, Lewy AJ: Melatonin and major affective disorders; in Miles A. Philbrich D. Thompson C (eds): Melatonin: Clinical Perspectives. New York. Oxford Medical Publications. 1988. pp 205-227.
22. Thompson C, Franey C, Arendt J, Checkley SA: A comparison of melatonin secretion in depressed patients and normal subjects. Psychiatry 1988:152:260-265.
23. Rubin RT, Heist EK, McGcoy SS, Ilanada K, Lesser IM: Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Arch Gen Psychiatry 1992:49:558-567.
24. Lewy AJ, Wehr TA, Gold PW, Goodwin FK: Plasma melatonin in manic-depressive illness; in Usdin E. Kopin IJ. Barchas J (eds): Catecholamines: Basic and Clinical Frontiers. Elmsford. Pergamon Press, 1979. vol 2, pp 1173-1175.
25. Branchey L, Weinberg U, Branchev M. Lin-kowsky P, Mendlewicz J: Simultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patients. Neurobiology 1982:8:225-232.
26. Beck-Friis J, von Rosen D, Kjellntan BF, Ljundgren JG. Wetterberg L: Melatonin in relation to body measures, sex. age. season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 1984:9:261-277.
27. Wetterberg L, Beck-Friis J, Aperia B, Petterson U: Melatonin/cortisol ratio in depression. Lancet 1979;ii: 13-61.
28. Kennedy SH, Tighe S, McVey G, Brown GM: Melatonin and cortisol "switches' during mania. depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis 1989:177: 300-303.
29. Wetterberg L, Aperia B, Beck-Friis I, Kjellntan BF, Ljunggren J-G, Petterson U, Sjolin A. Tham A, Undon F: Pincal-hypothalamic-pitu-itary function in patients with depressive illness: in Fuxc K. Gustafsson JA. Wetterberg L (eds): Steroid Hormone Regulation of the Brain. Elmsford. Pergamon Press. 1981. pp 397-403.
30. Wetterberg J, Aperia B, Beck-Friis J, Kjellntan BF, Ljunggren J-G, Nilsonne A, Petterson U. Tham A, Undcn F: Melatonin and cortisol levels in psychiatric illness. Lancet 1982;ii: 100.
31. Claustrat B, Chazot G, Brun J, Jordan D, Sas-solas G: A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984:19: 1215-1288.
32. Brisntar K, Werner S, Thoren M, Wetterberg L: Mctvraponc. An agent for melatonin as well as ACTH and cortisol secretion. J Endocrinol Invest 1985:8:91-95.
33. Young IM: The pineal indol hormones in Cushing's disease and acromegaly: in Mathews CD. Seamark RF (eds): Pineal Function. Amsterdam. Elsevier. 1981. pp 7-12.
34. Soszynski P, Stowinska-Srzednicka J, Kasper-lik-Zatuska A, Zgliczynski S: Decreased melatonin concentration in Cushing's syndrome. Homi Metab Res 1989:21:673-674.
35. Feuvre-Montagne M, Tourniaire J, Estour B, Bejard L: 24 hour melatonin secretory’ pattern in Cushing's syndrome. Clin Endocrinol 1983: 18:175-181.
36. Tourniaire J, Feuvre-Montangc M, Abou Sam-ra A. Dechaud H: Mélatoninect fonction corti-cotrope. Bull Acad Natl Med 1986; 170:803-809.
37. Feuvre-Montagne M, Abu-Samra A: Glucocorticoids inhibit the in vivo melatonin production by rat pineal gland stimulated by norepinephrine (NE) or 8-bromo-cyclic AMP (abstract 11). 14th Acta EndocrinolCongrSatellite Symposium. Stockholm. 1983.
38. Marinova C, Persengicv S, Konakchieva R, ilieva A. Patchev V: Melatonin effects on glucocorticoid receptors in rat brain and pituitary: Significance in adrenocortical regulation. Int J Biochcm 1991:23:479-481.
39. Sapoisky RM, Pulsinclli WA: Glucocorticoids potentiate ischemic injury to neurons: Therapeutic implications. Science 1985:229:1397-1400.
40. Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG: A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995:92: 1108-1112.
41. Lovenberg T, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB. Olters-dorf T: Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995;92:836-840.
42. McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJ: Cir-cumventricular organs: Neuroendocrine interfaces between the brain and the hcntal milieu. From Neuroendocrinol 1990:11:91-127.
43. Larsen PJ, Moller M, Mikkclsen JD: Efferent projections from the periventricular and medial parvicellular subnuclei of the hypothalamic paraventricular nucleus to circumventricular organs of the rat: A Phaseolus vulgaris-leucoag-glutinin (PHA-L) tracing study. J Comp Neurol 1991:306:462-479.
44. Gucrillol C, Pfister A, Muller J, De Lagc C: Recherche de l'origine des fibres nerveuses ex-traorthosympathctiques innervant l'epiphyse du rat (étude du transport rétrograde de la pér-oxidasede raifort). Rcprod Nutr Dev 1982:22: 371-378.
45. Korf HW, Moller M: The central innervation of the mammalian pineal gland; in Mess B. Ruzsas C. Tima L, Pevet P (eds): The Pineal Gland. Current State of Pineal Research. Amsterdam. Elsevier. 1985. pp 47-69.